The Fractalkine/CX3CR1 System Regulates β Cell Function and Insulin Secretion

Abstract

Here, we demonstrate that the fractalkine (FKN)/CX3CR1 system represents a regulatory mechanism for pancreatic islet β cell function and insulin secretion. CX3CR1 knockout (KO) mice exhibited a marked defect in glucose and GLP1-stimulated insulin secretion, and this defect was also observed invitro in isolated islets from CX3CR1 KO mice. Invivo administration of FKN improved glucose tolerance with an increase in insulin secretion. Invitro treatment of islets with FKN increased intracellular Ca(2+) and potentiated insulin secretion inboth mouse and human islets. The KO islets exhibited reduced expression of a set of genes necessary for the fully functional, differentiated β cell state, whereas treatment of wild-type (WT) islets with FKN led to increased expression of these genes. Lastly, expression of FKN in islets was decreased by aging and high-fat diet/obesity, suggesting that decreased FKN/CX3CR1 signaling could be a mechanism underlying β cell dysfunction in type 2 diabetes.